These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34027801)

  • 21. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.
    Toygar O; Guess MG; Youssef DS; Miller DM
    Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization.
    Çoban Karataş M; Yılmaz G; Yüce Sezen A; Sarıtürk Ç
    Turk J Ophthalmol; 2022 Feb; 52(1):45-49. PubMed ID: 35196839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
    Yang HS; Kim JG; Kim JT; Joe SG
    Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.
    Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D
    Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
    Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
    Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.
    Chen YC; Chen SN
    Br J Ophthalmol; 2020 Nov; 104(11):1561-1566. PubMed ID: 32051140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.
    Sahoo NK; Mishra SB; Iovino C; Singh SR; Munk MR; Berger L; Peiretti E; Chhablani J
    Br J Ophthalmol; 2019 Nov; 103(11):1615-1618. PubMed ID: 30602447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
    Maguire MG; Alexander J; Fine SL;
    Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.
    Karasu B; Gunay BO
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):99-106. PubMed ID: 31768680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events.
    Battaglia Parodi M; Di Bartolo E; Brue C; Cappello E; Furino C; Giuffrida S; Imparato M; Reibaldi M
    Eur J Ophthalmol; 2018 Jan; 28(1):58-62. PubMed ID: 29077191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.
    ; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM
    Arch Ophthalmol; 2007 Oct; 125(10):1323-30. PubMed ID: 17923538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.